Systemic application of sirolimus prevents neointima formation not via a direct anti-proliferative effect but via its anti-inflammatory properties
Keywords: α-SMA; α-smooth muscle actin; BMPC; bone marrow-derived progenitor cells; BMTx; bone marrow transplantation; CFSE; carboxyfluorescein succinimidyl ester; DES; drug-eluting stents; EC; endothelial cells; ICAM-1; intercellular adhesion molecule 1; mTOR; m